GUARDALBEN, Emanuele
 Distribuzione geografica
Continente #
NA - Nord America 353
EU - Europa 105
AS - Asia 62
Totale 520
Nazione #
US - Stati Uniti d'America 353
IT - Italia 34
CN - Cina 28
TR - Turchia 21
SE - Svezia 14
GB - Regno Unito 13
BE - Belgio 12
DE - Germania 11
PL - Polonia 8
SG - Singapore 6
UA - Ucraina 6
VN - Vietnam 5
CZ - Repubblica Ceca 2
FR - Francia 2
ID - Indonesia 2
AT - Austria 1
EE - Estonia 1
IE - Irlanda 1
Totale 520
Città #
Woodbridge 69
Fairfield 58
Ann Arbor 37
Ashburn 30
Ferrara 23
Chandler 22
Seattle 20
Houston 19
Cambridge 17
Wilmington 13
Brussels 12
Jacksonville 11
Beijing 9
New York 8
Warsaw 8
Izmir 7
Nanjing 7
Dong Ket 5
Addison 4
Boardman 4
Bremen 4
Milan 4
Princeton 4
Shanghai 3
Shenyang 3
Singapore 3
Brno 2
Jakarta 2
San Diego 2
Tianjin 2
Acton 1
Berlin 1
Changsha 1
Dublin 1
Edinburgh 1
Hebei 1
London 1
Nanchang 1
Ningbo 1
Norwalk 1
Orange 1
Tallinn 1
Vienna 1
Totale 425
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 179
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 119
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
Totale 528
Categoria #
all - tutte 2.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020116 17 3 6 16 9 13 15 9 14 5 5 4
2020/2021117 0 21 6 5 4 6 3 9 4 43 8 8
2021/202255 4 5 0 2 4 3 9 2 1 5 7 13
2022/202362 6 6 6 7 6 16 4 3 4 0 4 0
2023/202434 3 2 1 2 1 13 1 0 1 0 0 10
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 528